{"task_id": "902d231fb7208c68", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 377/464)", "text": "OSTIC ISSUES (CONT\u2019D)\nMelanoma and Skin Tumors\n369\n\n--- Page 391 ---\nMANAGEMENT (CONT\u2019D)\nlesions 1 4 mm thick, \u00053 cm for lesions >4 mm\nthick). Sentinel lymph node biopsy for lesions\n>1 mm thick. If palpable node or sentinel LN positive,\nconsider lymph node dissection and adjuvant\nhigh dose interferon a2b (5 days/week IV \u00034\nweeks, then 3 days/week SC \u000348 weeks). If extrano\ndal extension or LN >3 cm, consider adjuvant radia\ntion. For locoregional recurrence, consider re exci\nsion. Follow up of these patients should include a\ncomplete review of systems including headache,\nvisual changes, cough, lymph node examination,\nand for patients with deep melanomas an LDH\nand imaging to rule out metastasis. Patients should\ncontinue skin examinations at least semi annually\nfor new lesions as patients have a 3 5% chance of\ndeveloping another melanoma\nSTAGE IV\npalliative chemotherapy (dacarbazine\nwith response rate 15 20% and median duration of\nresponse 4 6 months. Consider temozolomide if CNS\nmetastases). Palliative radiation (if localized pain).\nExcision of solitary brain or lung metastasis is occa\nsionally done\nSPECIFIC ENTITIES\nDYSPLASTIC NEVI\nacquired moles characterized\nby cytologic atypia and architectural disorder. They\nremain dynamic throughout life, constantly appear\ning, changing, or disappearing\nDYSPLASTIC NEVUS SYNDROME\nmelanoma in \u00052\nblood relatives and dysplastic nevi in other family\nmembers\nBASAL CELL CARCINOMA\n\u0002\nPATHOPHYSIOLOGY\nthe most common form of skin\ncancer. Although they rarely metastasize, basal cell\ncarcinomas are locally destructive and must be\nremoved\n\u0002\nCLINICAL FEATURES\n\u0002\nNODULAR SUBTYPE (50 80%)\npearly semi trans\nlucent papules with telangiectasias and central\ndepression; may ulcerate crust or bleed\n\u0002\nSUPERFICIAL SUBTYPE (>15%)\npsoriasiform scaly\nplaque; most common on trunk and extremities\n\u0002\nPIGMENTED SUBTYPE (6%)\nmore common in\nLatin Americans and Asians\n\u0002\nMORPHEAFORM SUBTYPE (2 6%)\nwhite sclerotic\nplaque, can mimic a scar; predilection to recur\n\u0002\nRISK FACTORS\nhistory of prior sunburns (especially\nin childhood), radiation therapy, family history,\nimmunosuppression, fair complexion, and red hair\n\u0002\nTREATMENTS\nusually treated by either excision or\nelectrodessication and curettage. However, if super\nficial they may be treated with topical imiquimod\nACTINIC KERATOSIS\n\u0002\nPATHOPHYSIOLOGY\nform after chronic sun exposure\nin susceptible individuals usually on the face, scalp,\nSPECIFIC ENTITIES (CONT\u2019D)\nforearms, and dorsal hands. Actinic keratoses are\nfoci of superficial keratinocyte dysplasia capable of\nevolving into squamous cell skin cancer\n\u0002\nCLINICAL FEATURES\nthin pink to red papules and\nplaques with overlying scale, may sometimes con\ntain focal pigment. They are most common on\npeople with fair skin (type I or II) and occur with\nincreased frequency in patients who are immuno\nsuppressed or have received phototherapy\n\u0002\nTREATMENTS\ncryotherapy for focal lesions. If dif\nfuse damage is present, one may use topical imi\nquimod, 5 fluorouracil, diclofenac, trichloroacetic\nacid peels, and photodynamic therapy. If there is a\nthick component below the skin surface, one\nshould consider a skin biopsy to rule out under\nlying squamous cell carcinoma\nSQUAMOUS CELL CARCINOMA\n\u0002\nPATHOPHYSIOLOGY\nsecond most common form of\nskin cancer. On average 0.5 5.2% of squamous cell\ncarcinomas metastasize, but they are much more\naggressive on mucosal surfaces such as the lip and\nin areas of previous irradiation and scarring\n\u0002\nRISK FACTORS\nsame as risk factors for actinic ker\natoses, plus HPV infection for genital lesions\n\u0002\nCLINICAL FEATURES\ntypically firm red scaly plaques\nthat frequently become ulcerated and occur in\nareas of heavy sun exposure in fair skinned indivi\nduals. Subtypes include\n\u0002 BOWEN\u2019S DISEASE\nsquamouscellcarcinomainsitu\n\u0002\nERYTHROPLASIA OF QUEYRAT\nsquamous cell car\ncinoma in situ of the penis\n\u0002\nKERATOACANTHOMA\nrapidly developing volcano\nlike nodule that may spontaneously involute\n\u0002\nVERRUCOUS CARCINOMA\nclinically and histologi\ncally resembles a wart\n\u0002\nTREATMENTS\nsurgical excision is the treatment of\nchoice\nSEBORRHEIC KERATOSIS\n\u0002\nPATHOPHYSIOLOGY\nbenign tumor of keratinocytes.\nGenerally familial in nature\n\u0002\nCLINICAL FEATURES\nbenign skin colored to black\npapules and plaques with well defined borders.\nThey often have a warty surface and a stuck on\nappearance. Seborrheic keratoses are most com\nmonly located on the back but can occur on the\nhead, neck, and extremities. It is important to try to\ndifferentiate seborrheic keratoses clinically from\nmelanoma. The Leser Trelat sign denotes the sud\nden onset of numerous pruritic seborrheic kerato\nsis along with skin tags and acanthosis nigricans\nand may indicate underlying malignancy (adeno\ncarcinoma of the stomach and lung, leukemia,\nlymphoma, Sezary syndrome)\n\u0002\nTREATMENTS\nliquid nitrogen cryotherapy, curet\ntage, or shave removal\n370\nMelanoma and Skin Tumors", "text_length": 4877, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 377/464)", "type": "chunk", "chunk_index": 376, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.769595", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.770345", "status": "complete"